LivaNova (NSDQ:LIVN) announced today that it has agreed to sell its heart valve business to Gyrus Capital. London-based LivaNova’s board of directors unanimously approved the divestiture of the heart valve business in an effort to enable the company to “sharpen its focus” within its primary platforms, such as neuromodulation and cardiovascular, according to a news release. […]
Replacement Heart Valves
Boston Scientific CEO Mike Mahoney talks Lotus decision, post-COVID outlook
Boston Scientific (NYSE:BSX) made waves this month when it recalled and retired its Lotus TAVR product line. Subsequent layoffs, first in Minnesota, then in Ireland, highlighted the impact of the decision to pull Lotus from the highly competitive market as a result of complexities related to the product delivery system and solely that — as the […]
Next-gen MitraClip performs as well as earlier version
The award-winning next-generation MitraClip from Abbott (NYSE:ABT) reportedly performs as well as the previous version of the heart valve technology. According to reports in TCTMD, analysis presented by Abbott last week from its EXPAND registry compares favorably with outcomes seen in the landmark COAPT trial back in 2018. EXPAND was conducted across 57 locations in the […]
Boston Scientific’s Lotus layoffs extend to Ireland
Boston Scientific (NYSE:BSX) has reportedly confirmed job losses at its Galway, Ireland, location, following the retirement of the Lotus Edge. Galway Bay FM reported today that the Marlborough, Mass.-based company confirmed the job losses at its Ireland location, adding that Boston Scientific confirmed the job loss will affect fewer than 30 employees. The report said that […]
Boston Scientific to lay off 106 following Lotus Edge heart valve retirement
Boston Scientific (NYSE:BSX) is set to lay off 106 employees in Minnesota following the retirement of its Lotus Edge device, according to reports. Bring Me the News reported that the company is permanently laying off the 106 workers at its Maple Grove, Minn. location, having notified the state of Minnesota via a WARN letter, as is […]
Boston Scientific throws in the towel on Lotus TAVR
Boston Scientific (NYSE:BSX) announced today that it has initiated a global, voluntary recall of its Lotus Edge aortic valve system — and is immediately retiring the Lotus program. Marlborough, Mass.-based Boston Scientific said in a news release that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due […]
Medtronic updates instructions for potential risks with CoreValve R, CoreValve Pro TAVR devices
Medtronic (NYSE:MDT) issued a field safety notice to provide updates on rare potential risks with some of its TAVR devices. The CoreValve Evolut R and CoreValve Evolut Pro devices were listed in the notice as devices for which there were updates to the instructions for use manuals, specifically regarding the risk of transcatheter aortic valve (TAV) […]
Edwards reports better-than-expected Q3 results
Edwards Lifesciences (NYSE:EW) shares hardly moved after hours on third-quarter results that came in ahead of the consensus forecast. The Irvine, Calif.-based company posted profits of $325.2 million, or 52¢ per share, on sales of $1.14 billion for the three months ended Sept. 30, 2020, for an 18.4% bottom-line gain on sales growth of 4.3%. Adjusted […]
MedTech 100 roundup: Industry continues its ascent
Stocks in the medtech industry maintained their upward trajectory, topping last week’s peak with yet another rise to new heights. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 95.66 (Oct. 16), marking a 0.6% gain from the 95.05 points registered at the end of […]
The top 5 MassDevice stories of the week — October 16, 2020
For the second consecutive week, medtech giant Medtronic (NYSE:MDT) managed to dominate the news on MassDevice. The company’s “Investor Day” brought about several headlines, including new clinical trials ahead and a rallying cry from CEO Geoff Martha. Other news that garnered some attention came in the form of a new ultrasound system from another big player […]
Boston Scientific shares slide on TAVR study results
Shares in Boston Scientific (NYSE:BSX) slid nearly 4% on news that the rates of cardiac death in patients implanted with its Acurate Neo heart valve were significantly higher than those in patients who received Medtronic’s (NYSE:MDT) CoreValve Evolut. The head-to-head SCOPE II study, presented today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation, […]
